dvm360 product report: Handheld ultrasound, microbiome supplement, speech-to-text system and more
Heres our regular roundup of new and noteworthy veterinary products.
Handheld ultrasound device
The Butterfly iQ Vet is a handheld ultrasound device bringing ultrasound-on-a-chip technology to veterinarians. Butterfly iQ Vet has already impacted the healthcare of animals both large and small in unique locations around the world. From scanning manta rays underwater to sea turtles on beaches to pets on the exam table, its portability and reliability provide veterinarians the ability to make timely, precise diagnoses. The eventual goal of Butterfly iQ Vet is to put the device in the hands of consumers, giving pet owners a direct window into their animal's health to better understand and care for their pets in a reliable, cost-effective manner.
For more information visit butterflynetwork.com/vet/overview.
Gut restoration supplements
AnimalBiome uses the latest microbiome science to improve the health of dogs and cats. The company provides diagnostics and therapeutics to help veterinarians address chronic health conditions related to imbalances in the gut microbiome. AnimalBiome has the world's first stool bank for dogs and cats that is rigorously screened for pathogens, parasites and microbiome composition. In addition to offering gut health microbiome tests for pets, AnimalBiome has created gut restoration supplements that are delivered orally to treat symptoms like vomiting and diarrhea in cats and dogs.
For more information visit animalbiome.com.
Talkatoo is reinventing speech-to-text software by making it cross-platform and easier to use, saving its customers (busy professionals such as doctors, veterinarians and lawyers) time so they can get more done. Talkatoo works in any text field just like a keyboard; wherever you would type, you can talk instead. It can be used in practice management software systems, Microsoft Office, Google Docs and on the web. Talkatoo cuts clinic documentation time in half. The output is highly accurate so users spend less time correcting their notes. The product includes a robust veterinary vocabulary.
For more information visit talkatoo.com.
Fever-control injectable for horses
Kindred Biosciences recently announced that the FDA has approved Zimeta (dipyrone injection) for the control of pyrexia in horses. Pyrexia, or fever, is associated with a number of underlying diseases and can result in significant negative outcomes, including dehydration, laminitis, muscle wasting, weight loss and, in some, cases death. Among performance horses, fever can also lead to loss of training and competition days. Zimeta, which is classified as a nonsteroidal anti-inflammatory drug, targets fever centrally in the brain, where it originates. In a clinical study, Zimeta demonstrated rapid and effective fever reduction in horses with naturally occurring fever. Zimeta is administered intravenously at 30 mg/kg once or twice daily, at 12-hour intervals, for up to three days.
For more information visit kindredbio.com/zimeta.